Pay in 4 interest-free payments of $5.79 Learn more
Ships within 48 hours · Estimated delivery Aug 12 - Aug 17
Gold nanoparticles for biology and medicine
Oral Semaglutide and Cardiovascular Outcomes in Patients With Type 2 Diabetes (PIONEER 6) New England Journal of Medicine Demonstrated cardiovascular safety of oral semaglutide 14 mg daily versus placebo in 3,183 high-risk T2DM patients, with trend toward all-cause mortality reduction
Slowing Gastric Emptying: GLP drugs slow down the rate at which food leaves the stomach, helping people feel full longer after meals, further reducing hunger and calorie consumption
BPC157 Pentadecapeptide, TB500 Thymosin-B4, Amino Acid L-Lysine Do not exceed recommended dose, consult your doctor about research
Beetroot juice is fantastic for purifying the blood and clearing up the skin
GLP-1 medications require evaluation by a licensed clinician
US$ 23.78
US$ 28.55
US$ 21.89
US$ 25.20
US$ 23.80
US$ 28.56
